Restanza FDA Approval Status
FDA Approved: No
Brand name: Restanza
Generic name: cethromycin
Company: Advanced Life Sciences Holdings, Inc.
Treatment for: Pneumonia
Restanza (cethromycin) is a once-a-day oral antibiotic in development as a treatment for mild-to-moderate community acquired pneumonia (CAP).
Development timeline for Restanza
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
